Anhui Wanbang Pharmaceutical Technology Co (SZSE:301520) Interest Expense : ¥-0.8 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Anhui Wanbang Pharmaceutical Technology Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Anhui Wanbang Pharmaceutical Technology Co's interest expense for the three months ended in Mar. 2024 was ¥ 0.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-0.8 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Anhui Wanbang Pharmaceutical Technology Co's Operating Income for the three months ended in Mar. 2024 was ¥ 23.8 Mil. Anhui Wanbang Pharmaceutical Technology Co's Interest Expense for the three months ended in Mar. 2024 was ¥ 0.0 Mil. Anhui Wanbang Pharmaceutical Technology Co has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Anhui Wanbang Pharmaceutical Technology Co Interest Expense Historical Data

The historical data trend for Anhui Wanbang Pharmaceutical Technology Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Wanbang Pharmaceutical Technology Co Interest Expense Chart

Anhui Wanbang Pharmaceutical Technology Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.23

-0.01

-0.02

Anhui Wanbang Pharmaceutical Technology Co Quarterly Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial									-	-0.10	-	-0.71	-

Anhui Wanbang Pharmaceutical Technology Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.8 Mil.

Anhui Wanbang Pharmaceutical Technology Co (SZSE:301520) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Anhui Wanbang Pharmaceutical Technology Co's Interest Expense for the three months ended in Mar. 2024 was ¥0.0 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥23.8 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ¥0.0 Mil.

Anhui Wanbang Pharmaceutical Technology Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Anhui Wanbang Pharmaceutical Technology Co had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Anhui Wanbang Pharmaceutical Technology Co Ltd has no debt.

Anhui Wanbang Pharmaceutical Technology Co (SZSE:301520) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anhui Wanbang Pharmaceutical Technology Co Ltd (SZSE:301520) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

southwest corner of the intersection of Mingzhu Avenue and Huolongdi Road, Building 1, Anhui Wanbang Pharmaceutical, High-tech Zone, Anhui, Hefei, CHN, 230000

Website

http://www.ahwbyy.cn

Anhui Wanbang Pharmaceutical Technology Co Ltd is a one-stop CRO service platform that engages in the entire process from pharmaceutical development to clinical research of innovative drugs, improved new drugs and generic drugs. It aims to provide drug research and development and clinical trials for drug launch, including pharmaceutical research, clinical services, biological sample analysis and testing, SMO services and data statistics and analysis.

Anhui Wanbang Pharmaceutical Technology Co (SZSE:301520) Headlines

No Headlines